gayety.com /2 days ago

HIV Vaccine: Why There Isn’t One Yet, and What Comes Next

There's still no HIV vaccine. See why Mosaico and other big trials failed, what 2025 mRNA germline-targeting studies found and how the PrEP shot differs.

Read source
263chat.com /1 month ago

Zim Researchers Urged to Tackle Emerging HIV Complications

Zimbabwean researchers and health professionals have been urged to strengthen local research and collaboration to address emerging health challenges affecting people living with HI...

Read source
genengnews.com /2 weeks ago

HIV-Blocking Antibody Shows Promise, but Resistant Strains Break Through

A new study finds that the VRC01 antibody initially protects against HIV infection, but resistant strains can cause breakthrough infections as antibody levels decline, highlighting...

Read source
medicalxpress.com /4 weeks ago

International study helps support FDA approval of HIV drug for newborns

An international study conducted through the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network, including researchers at the University of Californ...

Read source
discovermagazine.com /3 weeks ago

An Experimental Antibody Kept HIV’s Monkey Counterpart in Remission for up to Four Years

Learn how a single dose of an antibody targeting immune cells helped some monkeys stay free of detectable virus long after stopping treatment.

Read source
washingtontimes.com /2 weeks ago

A promising new drug could turn the tide against HIV. But it is hard to find where it's needed most

In the red light district in Mbarara, a city in western Uganda known in part for sex tourism, a sex worker named Lisa Mutoni insists on using condoms when men enter her room, to pr...

Read source
rna-seqblog.com /3 days ago

Single-nucleus RNA sequencing identifies HIV-infected cells in the human brain

Single-nucleus RNA sequencing identifies microglia as the predominant HIV-infected brain cells, offering new insights into persistent viral reservoirs and neurological complication...

Read source
drugs.com /1 month ago

New Drug Combo Restores HIV Control

FRIDAY, Oct. 9, 2026 — A new long-acting drug combo can restore control over HIV for patients whose virus has developed resistance to commonly used medications, researchers report...

Read source
mwananchi.co.tz /3 weeks ago

Utafiti mpya waibua matumaini ya kudhibiti VVU bila ARV

Utafiti mpya wa kisayansi umeibua matumaini katika mapambano dhidi ya Virusi Vya Ukimwi (VVU), baada ya kubaini kuwa kingamwili maalumu zinaweza kuchelewesha kwa kiasi kikubwa kure...

Read source
nytimes.com /1 day ago

H.I.V. Research Networks May Again Seek Federal Funding, With a Twist

The Trump administration restarted the process for funding four large research networks after postponing it earlier this year.

Read source
jamaicainquirer.com /1 week ago

Zimbabwe’s HIV gains face a test among young people 

Harare, Zimbabwe – When Shaun Moyo started nursing at Parirenyatwa Hospital in Harare in the late 1990s, the effects o...

Read source
sciencealert.com /3 weeks ago

One Dose of Experimental Antibody Kept HIV-Like Virus in Remission For 4 Years in a Monkey

"May be a surprisingly effective route to HIV cure."ScienceAlert stories are written, fact-checked, and edited by humans, never generated by AI. Don't miss a story, subscribe here.

Read source
nytimes.com /1 month ago

Trump Administration Delays Threaten Funding for HIV Research

The networks also develop treatments and preventions for other infectious diseases and were instrumental in testing the Covid vaccine.

Read source
investing.com /1 month ago

Gilead to present HIV and antiviral research at IDWeek 2026

Read source
foreignpolicy.com /6 days ago

Can South Africa Tackle HIV Without the U.S.?

The rollout of a groundbreaking drug is an early test in a post-PEPFAR world.

Read source
scitechdaily.com /1 month ago

Long-Acting HIV Shots Could Solve a Major Treatment Challenge for Young People

A major African trial suggests that changing how HIV treatment is delivered could significantly improve viral suppression in adolescents. Young people with HIV were more likely to...

Read source
bioengineer.org /1 month ago

Stigma in the Clinic Strongly Predicts HIV Treatment Interruption in Kenya

Antiretroviral therapy has transformed HIV from a fatal diagnosis into a manageable chronic condition, but the benefits of treatment depend entirely on people taking their medicati...

Read source
newzimbabwe.com /1 month ago

New hope for TB prevention in people with HIV as experimental vaccine deemed safe

THE experimental M72/AS01 tuberculosis (TB) vaccine has shown a favourable safety profile in people living with HIV who are on antiretroviral therapy (ART), boosting prospects for...

Read source
wcpo.com /2 weeks ago

Approval of a generic HIV-prevention shot raises hopes in low-income countries

The U.S. Food and Drug Administration has approved a generic version of the world's only twice-a-year shot to prevent HIV — a big step toward making the drug available inexpensivel...

Read source
africanews.com /4 weeks ago

HIV prevention jab offers hope in Uganda but doses are hard to find

An injectable HIV drug could save huge numbers of people from getting infected in Uganda.
But shortages of lenacapavir mean that those who need it the most often can't get treate...

Read source
qcnews.com /2 weeks ago

Promising new HIV-prevention drug is hard to find where it's most needed, in places like Uganda

MBARARA, Uganda (AP) — In the red light district in Mbarara, a city in western Uganda known in part for sex tourism, a sex worker named Lisa Mutoni insists on using condoms when me...

Read source
bioengineer.org /3 hours ago

Anti-PD-1 Therapy Modulates HIV-Specific CD8+ T Cells in Men with HIV

A clinical trial of anti-PD-1 therapy in men with HIV and cancer demonstrates complex changes in HIV-specific CD8+ T-cell phenotypes and clonal distribution.

Read source
healthywomen.org /1 week ago

Treating HIV

Español Infographic text Treatment for HIV is called antiretroviral therapy (ART).ART involves taking a combination of HIV medicines on a regular schedule, called a treatment regi...

Read source
bioengineer.org /4 weeks ago

Pregnant adolescent refugees in Uganda reveal how they cope after HIV disclosure

A qualitative study of 40 pregnant adolescent refugees aged 15 to 19 living with HIV in Uganda's Nakivale Refugee Settlement found that disclosure was a selective, gradual process,...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.